Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 39: 503-508, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillery, P.
Right arrow Articles by Circaud, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillery, P.
Right arrow Articles by Circaud, R.

Clinical Chemistry, Vol 39, 503-508, Copyright © 1993 by American Association for Clinical Chemistry

Rate nephelometric assay of serum lipoprotein(a)

P Gillery, P Arthuis, C Cuperlier and R Circaud
Laboratory of Biochemistry, Centre Hospitalier Universitaire de Reims, Hopital Robert Debre, France.

This nephelometric assay of serum lipoprotein(a) [Lp(a)] is characterized by the use of a specific antibody to generate a high rate of light-scatter formation and the elimination of nonspecific reactions from serum samples by diluting samples in phosphate-buffered saline containing polymer enhancer polyethylene glycol (PEG), 40 g/L, and detergent before the assay. We reacted 100 microL of sixfold-diluted serum in 500 microL of buffer containing PEG with 42 microL of pure polyclonal rabbit antiserum (Dakopatts) directed against human Lp(a) and monitored the reaction by rate nephelometry with the Array Protein System nephelometer (Beckman). The standard curve for the reaction was linear in the Lp(a) range 10-1280 mg/L; antigen excess occurred between 1300 and 1400 mg/L. Calibration was performed with serial dilutions of a standard serum. Precision studies showed within-run and between-run CVs of < 2.1% and 6.9%, respectively. The nephelometric results (y) for 100 serum samples were highly correlated with those obtained by radial immunodiffusion (x) calibrated with the same materials: y = 1.07 (+/- 0.03) x - 16.2 (+/- 8.1) mg/L (r = 0.974, P < 0.001). Storing serum for 3 weeks at 4 degrees C or 3 months at -80 degrees C did not affect the results.


The following articles in journals at HighWire Press have cited this article:


Home page
StrokeHome page
B. Smolders, R. Lemmens, and V. Thijs
Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies
Stroke, June 1, 2007; 38(6): 1959 - 1966.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. Anglés-Cano, S. Loyau, G. Cardoso-Saldaña, R. Couderc, and P. Gillery
A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping
J. Lipid Res., February 1, 1999; 40(2): 354 - 359.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
F. Lefevre, G. Moutel, F. Carre-Pigeon, J. Caron, and P. Gillery
Automated Nephelometric Assay for Seminal Fluid Transferrin
Clin. Chem., December 1, 1998; 44(12): 2544 - 2546.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.